 |
|
|
| |
No Pharmacokinetic Interaction Between the Hepatitis C Virus Non-Structural Protein 5A Inhibitor MK-8742 and Ethinyl Estradiol and Levonorgestrel
|
| |
| |
Reported by Jules Levin
HEP DART Dec 8-12 2013
Biennial Frontiers in Drug Development for Viral Hepatitis
The Big Island, Hawaii
WL Marshall1, WW Yeh1, L Caro1, S Langley1, J Ma1, E Mangin1, X Huang1, R Valesky1, TE O'Reilly2, and JR Butterton1
1Merck, Whitehouse Station NJ, USA; 2Celerion, Phoenix, AZ, USA
|
| |
|
|
|
|
|
